Coggeshall RE, Carlton SM Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J Comp Neurol. 1998 Feb 2;391(1):78-86.
Davidson EM, Coggeshall RE, Carlton SM Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport. 1997 Mar 3;8(4):941-6.
Gammaitoni AR, Alvarez NA, Galer BS Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003 Feb;43(2):111-7. Review.
Griffin JR, Davis MD Amitriptyline/Ketamine as therapy for neuropathic pruritus and pain secondary to herpes zoster. J Drugs Dermatol. 2015 Feb;14(2):115-8.
LaMotte RH, Dong X, Ringkamp M Sensory neurons and circuits mediating itch. Nat Rev Neurosci. 2014 Jan;15(1):19-31. doi: 10.1038/nrn3641. Review.
LaMotte RH, Shimada SG, Green BG, Zelterman D Pruritic and nociceptive sensations and dysesthesias from a spicule of cowhage. J Neurophysiol. 2009 Mar;101(3):1430-43. doi: 10.1152/jn.91268.2008. Epub 2009 Jan 14.
Leknes SG, Bantick S, Willis CM, Wilkinson JD, Wise RG, Tracey I Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J Neurophysiol. 2007 Jan;97(1):415-22. Epub 2006 Aug 16.
Lynch ME, Clark AJ, Sawynok J, Sullivan MJ Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005 Jul;103(1):140-6.
Lynch ME, Clark AJ, Sawynok J A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003 Sep-Oct;19(5):323-8.
Mehta AK, Halder S, Khanna N, Tandon OP, Singh UR, Sharma KK Role of NMDA and opioid receptors in neuropathic pain induced by chronic constriction injury of sciatic nerve in rats. J Basic Clin Physiol Pharmacol. 2012;23(2):49-55. doi: 10.1515/jbcpp-2012-0003.
Papoiu AD, Coghill RC, Kraft RA, Wang H, Yosipovitch G A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage. 2012 Feb 15;59(4):3611-23. doi: 10.1016/j.neuroimage.2011.10.099. Epub 2011 Nov 12.
Papoiu AD, Tey HL, Coghill RC, Wang H, Yosipovitch G Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch. PLoS One. 2011 Mar 14;6(3):e17786. doi: 10.1371/journal.pone.0017786.
Patel T, Yosipovitch G Therapy of pruritus. Expert Opin Pharmacother. 2010 Jul;11(10):1673-82. doi: 10.1517/14656566.2010.484420. Review.
Reddy VB, Iuga AO, Shimada SG, LaMotte RH, Lerner EA Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci. 2008 Apr 23;28(17):4331-5. doi: 10.1523/JNEUROSCI.0716-08.2008.
Sandroni P, Davis MD Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option? Arch Dermatol. 2006 Mar;142(3):283-6.
Sawynok J Topical analgesics for neuropathic pain in the elderly: current and future prospects. Drugs Aging. 2014 Dec;31(12):853-62. doi: 10.1007/s40266-014-0218-9. Review.
Selcuk E, Ertürk S, Afrashi A An adverse reaction to local anaesthesia: report of a case. Dent Update. 1996 Oct;23(8):345-6. Review.
Sikand P, Shimada SG, Green BG, LaMotte RH Sensory responses to injection and punctate application of capsaicin and histamine to the skin. Pain. 2011 Nov;152(11):2485-94. doi: 10.1016/j.pain.2011.06.001. Epub 2011 Jul 29.
Sikand P, Shimada SG, Green BG, LaMotte RH Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage. Pain. 2009 Jul;144(1-2):66-75. doi: 10.1016/j.pain.2009.03.001. Epub 2009 May 6.
Ständer S, Schmelz M Chronic itch and pain--similarities and differences. Eur J Pain. 2006 Jul;10(5):473-8. Epub 2006 May 5. Review.
Sullivan RW, Ryzewski M, Holland MG, Marraffa JM Compounded ointment results in severe toxicity in a pediatric patient. Pediatr Emerg Care. 2013 Nov;29(11):1220-2. doi: 10.1097/PEC.0b013e3182aa4748.
Tam E, Furlan AD Transdermal lidocaine and ketamine for neuropathic pain: a study of effectiveness and tolerability. Open Neurol J. 2012;6:58-64. doi: 10.2174/1874205X01206010058. Epub 2012 Jun 28.
Tey HL, Yosipovitch G Targeted treatment of pruritus: a look into the future. Br J Dermatol. 2011 Jul;165(1):5-17. doi: 10.1111/j.1365-2133.2011.10217.x. Epub 2011 May 30. Review.
Uzaraga I, Gerbis B, Holwerda E, Gillis D, Wai E Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study. Support Care Cancer. 2012 Jul;20(7):1515-24. doi: 10.1007/s00520-011-1240-7. Epub 2011 Aug 17.
Wahlgren CF Itch and atopic dermatitis: an overview. J Dermatol. 1999 Nov;26(11):770-9. Review.
Zhou S, Bonasera L, Carlton SM Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport. 1996 Mar 22;7(4):895-900.
Zylka MJ, Rice FL, Anderson DJ Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd. Neuron. 2005 Jan 6;45(1):17-25.
Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.